ArticleJournal of thoracic disease2025
Association between red blood cell distribution width to albumin ratio (RAR) and long-term prognosis of patients with sudden cardiac arrest.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The association between the red blood cell distribution width-to-albumin ratio and in-hospital mortality in cardiac arrest patients: an analysis of the eICU database.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Red blood cell distribution width to albumin ratio (RAR) is associated with adverse outcomes in a variety of clinical conditions. However, the potential connection between RAR and the prognostic outcome of patients with sudden cardiac arrest (CA) remains uncharted. Hence, this study emphasizes elucidating the relevance between RAR and adverse prognosis in patients with sudden CA. Methods: Our study, a retrospective cohort analysis, used data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) version 3.0 database. The 1-year mortality rate was the principal endpoint of this study, the subordinate outcomes included the 5-year, 28-day, 90-day, and in-hospital mortality rates. Cox models, cubic spline models, and subgroup analyses assessed the link between RAR and mortality rates. Results: This study included a total of 1,673 participants. The study found that in the groups with in-hospital, 28-day, 90-day, 1-year and 5-year death rates, the median RAR of those who passed away was notably higher than that of those who survived. When the participants were grouped based on RAR tripartite number, it was observed that in the higher RAR groups, the numbers of deaths at various intervals (in-hospital, 28-day, 90-day, 1-year, and 5-year) showed significant increases. After adjusting for other factors, it was discovered that for the 1-year death rate, the risk was 1.27 times higher in the Q2 group (4.51-5.77) and 1.42 times higher in the Q3 group (>5.77) (with a confidence level of 95%), showing statistical significance. Similar patterns were found in the 28-day, 90-day, and 5-year death rates. However, this pattern was not seen in patients with in-hospital mortality. Besides, the analysis indicated a significant nonlinear relationship between RAR and the 1-year, 5-year death rate. The model constructed using the variables selected through least absolute shrinkage and selection operator (Lasso) regression analysis for predicting the clinical prognosis of patients with sudden CA demonstrated good discriminative ability, accuracy, and clinical utility. Conclusions: Our research has found a close association between RAR and the long-term adverse clinical outcomes of patients with sudden CA. The higher the RAR, the higher the mortality rates at 28 days, 90 days, 1 year and 5 years. A clinical model based on RAR for predicting the prognosis of patients with sudden CA can provide a convenient and accurate scoring system for evaluating their prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.